Reem Alrabeh/LinkedIn
Sep 6, 2026, 11:58
Reem Alrabeh: An Honorable Meeting with a Leader in Hematopathology
Reem Alrabeh, Chairperson of the Scientific Council of Hematopathology at Saudi Commission for Health Specialties, Consultant Pathologist, Chairperson – Hematology and Flow Cytometry Laboratory, Chairperson – Cytogenetic Laboratory at King Fahad Specialist Hospital Dammam, shared a post on LinkedIn:
“It was an honor meeting Dr. Robert Hasserjian, who is a prominent figure in the field of hematopathology.
His contributions to the understanding of hematologic disorders and the advancement of diagnostic techniques make him an influential mentor and a thought leader.
Thank you Dr. Rania Medhat Seliem for inviting me to this special event.”

Stay updated with Hemostasis Today.
Clinical Pathology
Diagnostic Pathology
EHC 2026
Emirates Haematology Conference
Flow cytometry
healthcare
Hematologic Disorders
Hematologic Malignancies
Hematology
Hematopathology
Hemostasis News
Hemostasis Today
Laboratory Medicine
medical education
Medical Leadership
Medical Mentorship
Medical Research
Pathology
Professional Development
Rania Medhat Seliem
Reem Alrabeh
Robert Hasserjian
-
Sep 6, 2026, 10:52Panagiotis Christoforou: Six Years of Service, Growth and Global Connection with WFH
-
Sep 6, 2026, 10:51Amer Zeidan: Looking Ahead to ESH MDS 2026 in Ireland
-
Sep 6, 2026, 10:50David Smadja: Unveiling the Endothelium’s Role in Thrombosis at ISTH 2026
-
Sep 6, 2026, 10:48Tareq Abadl: When and Why Do We Perform Weak D Testing?
-
Sep 6, 2026, 10:19Faezeh Kheyri: Exploring the Future of Immunohematology with Artificial Intelligence
-
Sep 6, 2026, 05:58Mohamed F Doheim: ‘Stroke as a Symphony’ – Rethinking Decision-Making in Acute Ischemic Stroke
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients